Trial Profile
A Retrospective, Multicenter Study to Assess the Efficacy and Safety of Conversion to Belatacept in a Large Cohort of Patients in a Real-Life Setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2018
Price :
$35
*
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 29 Mar 2018 New trial record
- 22 Mar 2018 Results published in the Transplantation Journal.